Fig. 5From: The efficacy and safety of tenecteplase compared with alteplase in adult patients with acute ischemic stroke: an updated systematic review and meta-analysis of ten randomized controlled trialsA Funnel plots of efficacy outcome measures illustrating publication bias. A: Early neurological improvement; B: Recanalization; C: mRS 0–1 at 90-days; and D: mRS 0–2 at 90-days. CI Confidence interval, mRS modified Rankin Scale. B Funnel plots of safety outcome measures illustrating publication bias. A Any ICH, B Symptomatic ICH, C mRS All-cause mortality. CI Confidence interval, mRS modified Rankin ScaleBack to article page